These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25212850)

  • 21. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
    Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
    Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.
    Ye L; Rasmussen J; Kaeser SA; Marzesco AM; Obermüller U; Mahler J; Schelle J; Odenthal J; Krüger C; Fritschi SK; Walker LC; Staufenbiel M; Baumann F; Jucker M
    EMBO Rep; 2017 Sep; 18(9):1536-1544. PubMed ID: 28701326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H; Yang H; Xie Z; Wang P; Bi J
    Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.
    Lombardi G; Berti V; Tedde A; Bagnoli S; Piaceri I; Polito C; Lucidi G; Ferrari C; Ginestroni A; Moretti M; Pupi A; Nacmias B; Sorbi S
    J Alzheimers Dis; 2017; 57(3):697-703. PubMed ID: 28304299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid induction of Alzheimer A beta amyloid formation by zinc.
    Bush AI; Pettingell WH; Multhaup G; d Paradis M; Vonsattel JP; Gusella JF; Beyreuther K; Masters CL; Tanzi RE
    Science; 1994 Sep; 265(5177):1464-7. PubMed ID: 8073293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease.
    Green PS; Bales K; Paul S; Bu G
    Endocrinology; 2005 Jun; 146(6):2774-81. PubMed ID: 15731362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.
    Kalback W; Watson MD; Kokjohn TA; Kuo YM; Weiss N; Luehrs DC; Lopez J; Brune D; Sisodia SS; Staufenbiel M; Emmerling M; Roher AE
    Biochemistry; 2002 Jan; 41(3):922-8. PubMed ID: 11790115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
    Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
    Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
    Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
    Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-β in the Cerebrospinal Fluid of APP Transgenic Mice Does not Show Prion-like Properties.
    Skachokova Z; Sprenger F; Breu K; Abramowski D; Clavaguera F; Hench J; Staufenbiel M; Tolnay M; Winkler DT
    Curr Alzheimer Res; 2015; 12(9):886-91. PubMed ID: 26159190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.